|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Dinoprostonevaginal slow-release system(Propess)compared to ex-pectant management in the active treatment of prematurerupture of the membranes at term:impact on maternal andfetal outcomes显示文摘 | Sarsam DS Shamden M Al Wazan R | 2008 | Acta Obstet Gynecol2008，87，： | 1 |
| 2 | Expectant versus aggressive management in severe preeclampsia remote from term显示文摘 | Sarsam DS Shamden M Al Wazan R | 2008 | Singapore Med J2008，49，9： | 1 |
| 3 | A secure collaborative web based environment for virtual organizations显示文摘 | R Laborde M Kamel S Wazan | 2009 | International Journal of Web Based Communities2009，5，2： | 1 |
| 4 | Expectant versus aggressive management in severe preeclampsia remote from term显示文摘 | Sarsam DS Shamden M Al Wazan R | 2008 | Singapore Med J2008，49，9： | 1 |
| 5 | Expectant versus aggressive management in severe preeclampsia remote from term显示文摘 | Sarsam DS Shamden M A1 Wazan R | 2008 | Singapore Med J2008，49，9： | 1 |
| 6 | Expectant versus aggressive management in severe preeclampsia remote from trerm 显示文摘 | Sarsam DS Shamden M AL Wazan R | 2008 | Singapote Med J2008，49，9： | 1 |
| 7 | Using transcription factors for direct reprogramming of neurons in vitro显示文摘Cell therapy offers great promises in replacing the neurons lost due to neurodegenerative diseases or injuries.However,a key challenge is the cellular source for transplantation which is often limited by donor availability.Direct reprogramming provides an exciting avenue to generate specialized neuron subtypes in vitro,which have the potential to be used for autologous transplantation,as well as generation of patient-specific disease models in the lab for drug discovery and testing gene therapy.Here we present a detailed review on transcription factors that promote direct reprogramming of specific neuronal subtypes with particular focus on glutamatergic,GABAergic,dopaminergic,sensory and retinal neurons.We will discuss the developmental role of master transcriptional regulators and specification factors for neuronal subtypes,and summarize their use in promoting direct reprogramming into different neuronal subtypes.Furthermore,we will discuss up-and-coming technologies that advance the cell reprogramming field,including the use of computational prediction of reprogramming factors,opportunity of cellular reprogramming using small chemicals and microRNA,as well as the exciting potential for applying direct reprogramming in vivo as a novel approach to promote neuro-regeneration within the body.Finally,we will highlight the clinical potential of direct reprogramming and discuss the hurdles that need to be overcome for clinical translation. | Layal El Wazan Daniel Urrutia-Cabrera Raymond Ching-Bong Wong | 2019 | World Journal of Stem Cells2019，11，7： | 1 |
| 8 | Expectant versus aggressive management in severe preeclampsia remote from term 显示文摘 | Sarsam DS Shamden M A1 Wazan R | 2008 | Singa- pore Med J2008，49，9： | 1 |
| 9 | Expectant versus aggressive manage- ment in severe preeclampsia remote from term 显示文摘 | Sarsam DS Shamden M AI Wazan R | 2008 | Singapore Med J2008，49，9： | 1 |
| 10 | Expectant versus aggressive management in severe preeclampsia remote from term 显示文摘 | Sarsam DS Shamden M AI Wazan R | 2008 | Singapore Med J2008，49，9： | 1 |
| 11 | Expectant versus aggressive management in severe preeclampsia remote from term 显示文摘 | Sarsam DS Shamden M A1 Wazan R | 2008 | Singapore Med J2008，49，9： | 1 |
| 12 | Expectant versus aggressive management in severe preeclampsia remote from term显示文摘 | Sarsam DS Shamden M AI Wazan R | | 0，，09： | 1 |
| 13 | Expectant versus aggressive management in severe preeclampsia remote from term显示文摘 | $arsam DS l Shamden M AI Wazan R | 2008 | Singapore Med J2008，49，9： | 1 |
| 14 | Expectant versusaggressive management in severe preeclampsia remote fromterm显示文摘 | Sarsam DS Shamden M Al Wazan R | 2008 | Singapore Med J2008，49，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员